Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome

Area of Science:

• Genetics
• Cell Biology
• Neuroscience

Background:

• Down syndrome (DS), caused by Trisomy 21, presents complex pathological phenotypes including mitochondrial dysfunction, neuroinflammation, and oxidative stress.
• Chromosome 21 triplication and missegregation contribute to inflammation and redox imbalance in DS.
• Autophagy is a crucial cellular mechanism for maintaining homeostasis by degrading damaged components.

Purpose of the Study:

• To review the role of autophagy in regulating inflammation and redox homeostasis in Down syndrome.
• To explore the interconnectedness of autophagy, inflammation, and oxidative stress in DS.
• To identify potential therapeutic targets within the autophagy pathway for aneuploidy-associated diseases.

Main Methods:

• Literature review focusing on the role of autophagy in Down syndrome.
• Analysis of the interplay between autophagy, inflammation, and redox balance in DS.
• Synthesis of current knowledge on therapeutic strategies targeting autophagy in DS.

Main Results:

• Autophagy dysfunction is implicated in the pathogenesis of Down syndrome.
• Modulating autophagy can help mitigate neuroinflammation and oxidative stress in DS.
• Autophagy is a critical regulator of cellular homeostasis in the context of Trisomy 21.

Conclusions:

• Autophagy is a key player in managing inflammation and redox homeostasis in Down syndrome.
• Targeting autophagy presents a promising therapeutic avenue for Down syndrome.
• Understanding autophagy's role offers insights into treating aneuploidy-associated neurological disorders.